Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary liver cancers

A Weimann1, K J Oldhafer, R Pichlmayr

  • 1Klinik für Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, Germany.

Current Opinion in Oncology
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus-version 4.0.

ESMO gastrointestinal oncology·2026
Same author

Individual multimodal prehabilitation in high-risk patients undergoing major abdominal surgery following neoadjuvant treatment - a feasibility study.

Langenbeck's archives of surgery·2025
Same author

Quality-of-care standards in adult type 3 intestinal failure caused by benign disease: A European society of clinical nutrition and metabolism (ESPEN) position paper.

Clinical nutrition ESPEN·2024
Same author

Metachronous hepatic resection for liver only pancreatic metastases.

Surgical oncology·2020
Same author

[S3 Guideline Sepsis-prevention, diagnosis, therapy, and aftercare : Long version].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2020
Same author

ASO Author Reflections: Hybrid-ALPPS Followed by Ante Situm with Cardiopulmonary Bypass: Pushing the Boundaries for Resectability by Combining Two Controversial Methods.

Annals of surgical oncology·2020
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Hepatitis C is a growing risk factor for liver cancer (hepatocellular carcinoma). Early detection and surgical resection are key, with transplantation and multimodality treatments offering improved survival for select patients.

Area of Science:

  • Hepatology
  • Oncology
  • Gastroenterology

Background:

  • Hepatocellular carcinoma (HCC) incidence is rising, with hepatitis C virus (HCV) infection playing an increasing role.
  • Emerging research explores the link between oral contraceptive use and HCC development.
  • Identifying at-risk populations for early cancer detection is crucial.

Purpose of the Study:

  • To review current literature on liver cancer, focusing on risk factors, diagnosis, and treatment modalities.
  • To discuss the evolving role of hepatitis C and oral contraceptives in HCC pathogenesis.
  • To outline current and emerging therapeutic strategies for hepatocellular carcinoma.

Main Methods:

  • Comprehensive literature review of recent studies on liver cancer.
  • Analysis of epidemiological data and clinical trial outcomes.

Related Experiment Videos

  • Synthesis of evidence regarding risk factors and treatment efficacy.

    • Main Results:

    • Hepatitis C is a significant and increasing risk factor for HCC.
    • The association between oral contraceptives and HCC is under active investigation.
    • Surgical resection is the primary treatment for resectable HCC.
    • Liver transplantation is reserved for specific unresectable cases or early resectable HCC in cirrhotic patients.
    • Multimodality treatments show promise for improving survival.
    • Transarterial chemoembolization and percutaneous ethanol injection are effective for unresectable or small lesions, respectively.

    Conclusions:

    • Early detection and surgical resection are vital for managing hepatocellular carcinoma.
    • Liver transplantation and multimodality therapies offer improved outcomes for selected patients.
    • Further research is needed on immunosuppression's role in HCC recurrence and the oral contraceptive link.